- Earlier this week, a senior vice president at Allegro MicroSystems sold approximately US$101,000 of company stock, while Benchmark initiated analyst coverage with a positive rating.
- Together, the insider sale and fresh analyst attention highlight how differing signals from company insiders and external researchers can influence investor perception of Allegro’s outlook.
- We’ll now examine how Benchmark’s upbeat coverage initiation shapes Allegro MicroSystems’ existing investment narrative and what it could mean for investors.
AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
Allegro MicroSystems Investment Narrative Recap
To own Allegro MicroSystems, you need to believe its sensor and power IC portfolio can keep winning content in electric vehicles, ADAS, and high‑growth industrial and data center applications. Benchmark’s upbeat coverage and the short term share price jump do not materially change the key near term catalyst, which remains execution against its strong Q2 sales guidance, or the main risk, which is margin pressure from pricing, competition, and Allegro’s high investment needs.
The most relevant recent development is Allegro’s Q1 FY2026 update, where it returned to profitability and guided Q2 net sales to US$265 million to US$275 million, implying solid year over year growth. That operational progress provides the backdrop for Benchmark’s positive rating, since any analyst enthusiasm now sits alongside evidence that Allegro is converting its product wins in EV, industrial automation, and data centers into higher revenue and improving earnings quality.
Yet in contrast, investors should also be aware of how ongoing price pressure and elevated R&D spending could weigh on Allegro’s margins and free cash flow…
Read the full narrative on Allegro MicroSystems (it’s free!)
Allegro MicroSystems’ narrative projects $1.4 billion revenue and $223.5 million earnings by 2029. This requires 17.3% yearly revenue growth and a $238.4 million earnings increase from -$14.9 million today.
Uncover how Allegro MicroSystems’ forecasts yield a $56.55 fair value, a 27% upside to its current price.
Exploring Other Perspectives
Some of the lowest ranked analysts tell a much more cautious story, expecting roughly 14.6 percent annual revenue growth and slower margin recovery, which contrasts with Benchmark’s optimism and highlights how your view on Allegro’s outlook and risks could evolve as this new coverage and insider activity are digested.
Explore 4 other fair value estimates on Allegro MicroSystems – why the stock might be worth as much as 40% more than the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Allegro MicroSystems research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
- Our free Allegro MicroSystems research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate Allegro MicroSystems’ overall financial health at a glance.
Want Some Alternatives?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
- We’ve uncovered the 10 dividend fortresses yielding 5%+ that don’t just survive market storms, but thrive in them.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com